Lonza Group Business Operations and Performance Metrics

Lonza Group is a global biotechnology company that operates in the pharmaceutical, biotech, and nutrition industries. The company was founded in 1897 in Basel, Switzerland.

Lonza has a significant presence in the US, with major operations in North Carolina and Massachusetts. Its US operations account for a substantial portion of the company's revenue.

Lonza's business operations are divided into three main segments: Biopharma, Consumer Health, and Nutrition. The Biopharma segment focuses on the development and manufacture of APIs and biologics.

Here's an interesting read: Statera BioPharma

Lonza Group has a significant global presence with over thirty development and manufacturing sites across countries including Switzerland, the United States, the United Kingdom, and more.

The company employs approximately 18,000 people across more than 30 locations as of 2023. This large workforce enables Lonza to operate efficiently and effectively in its various locations.

In 2024, Lonza announced plans to streamline its operations by exiting the capsules and health ingredients sector, a decision that is expected to enhance the company's growth prospects and financial stability.

Lonza has a significant presence globally, with over thirty development and manufacturing sites across countries like Switzerland, the United States, the United Kingdom, and more.

The company has established a presence in India, breaking ground in Genome Valley in 2011, and has also expanded its operations in the United States with a 300,000 square feet facility in Pearland, Texas.

As of 2023, Lonza employed approximately 18,000 people across more than 30 locations worldwide.

In 2024, Lonza announced plans to streamline its operations by exiting the capsules and health ingredients sector, which accounts for 17% of its 2023 revenue.

The company intends to focus on its core business as a contract development and manufacturing organization (CDMO), with a focus on three platforms: integrated biologics, advanced synthesis, and specialized modalities.

Lonza is the global leader in producing monoclonal antibodies, a key technology behind new Alzheimer's treatments.

Here are some key statistics about Lonza's business operations:

Improving competitive bidding is crucial for businesses, and one way to do this is by gaining insights into publicly disclosed IT services contracts.

You can find publicly disclosed IT services contracts for companies like Lonza Group Ltd, which includes contracts for IT outsourcing, business process outsourcing, systems integration, and consulting.

This information can be incredibly valuable for businesses looking to make informed decisions about their own IT services contracts.

For example, Lonza Group Ltd has publicly disclosed IT services contracts, which can be a great resource for businesses looking to learn from others' experiences.

By analyzing these contracts, you can gain a better understanding of the terms, conditions, and pricing associated with different IT services.

This can help you make more informed decisions about your own IT services contracts and improve your competitive bidding strategy.

Discover more: Scalable Creative Solutions Large Businesses

Lonza Group AG's sales by activity show a diverse range of products and services.

The company's biologics sales have been steadily increasing, reaching 3.68 billion in 2024.

Advanced synthesis sales have also seen growth, with 985 million in sales for 2024.

Specialized modalities sales have remained relatively stable, with 745 million in sales for 2024.

Capsules and health ingredients sales have been decreasing, with 1.06 billion in sales for 2024.

Corporate and eliminations sales have fluctuated, with 109 million in sales for 2024.

Here's a breakdown of Lonza Group AG's sales by activity for 2024:

Sales by Geography is a crucial aspect of Lonza Group AG's business strategy. The company has a significant presence in various regions, with the United States being its largest market, accounting for $2.57B in sales in 2020.

The United States has consistently been the largest market for Lonza Group AG, with sales ranging from $2.12B in 2021 to $2.31B in 2024. In contrast, Switzerland, the company's home country, has seen a decline in sales, from $635M in 2020 to $719M in 2024.

Switzerland is followed closely by Ireland, which has seen an increase in sales, from $265M in 2020 to $457M in 2024. Japan, another significant market, has experienced fluctuations in sales, ranging from $218M in 2020 to $544M in 2023.

Here is a breakdown of the top 5 markets for Lonza Group AG in 2020:

Germany, Denmark, and the United Kingdom are also significant markets for Lonza Group AG, with sales ranging from $221M to $322M in 2023.

Lonza Group has a strong financial foundation, with a revenue of CHF 4.9 billion in 2020.

The company has a diverse revenue stream, with 55% of its revenue coming from the Biopharma segment, 24% from the Bioscience segment, and 21% from the Nutrition & Consumer Goods segment.

Lonza Group has a significant presence in the global market, with operations in over 100 countries and a workforce of over 13,000 employees.

Having access to premium industry data, like Lonza Group Ltd's, can be a game-changer for businesses. This type of data helps you stay up-to-date on the latest market trends and shifts.

Lonza Group Ltd's premium industry data and analytics can identify which of their products will be commercialized. This information can be used to better contend with shifting product portfolios.

Staying one step ahead of the market is crucial for businesses to remain competitive. With Lonza Group Ltd's premium industry data, you can make informed decisions about your own product portfolio.

Identifying commercialized products can help you adjust your business strategy accordingly. This proactive approach can lead to increased success and reduced risk.

By leveraging premium industry data, you can gain a deeper understanding of the market and make data-driven decisions.

Recommended read: Do Businesses Prefer Cash or Credit

Analysts' consensus is a crucial metric in financial analysis. It represents the average recommendation or rating given by a group of analysts who cover a particular stock.

A high consensus rating, typically above 4, indicates that most analysts are bullish on the stock. Conversely, a low consensus rating, typically below 2, suggests that most analysts are bearish.

The consensus rating can be influenced by the number of analysts covering the stock, with more analysts providing a more accurate representation of market sentiment. A higher number of analysts, typically above 20, can provide a more robust consensus rating.

Analysts' consensus is not a guarantee of future stock performance, but it can be a useful tool in making informed investment decisions.

Additional reading: What Types of Investments Are Typically in Target Date Funds

Lonza Group has a well-established leadership and governance structure. The company is led by CEO Wolfgang Wienand, who has been in his role since June 30, 2024, at the age of 53.

The Executive Committee consists of four members, including Wienand, Director of Finance Philippe Deecke, Investor Relations Contact Daniel Buchta, and General Counsel Andreas Bohrer, who has been with the company since December 31, 2014. Chief Operating Officer Maria Nunez, who is 56 years old, joined the company on July 31, 2022.

The Board of Directors is composed of eight members, including Chairman R. Jean-Marc Sidney Huët, who took on the role on May 7, 2024, at the age of 56. Other notable members include Director/Board Member Barbara Richmond, who has been with the company since April 15, 2014, at the age of 65, and Director/Board Member Juan Andres, who joined the company on May 8, 2025, at the age of 60.

Here is a list of the current members of the Executive Committee and the Board of Directors:

The Executive Committee plays a crucial role in shaping the direction of Lonza Group AG. The committee is led by Wolfgang Wienand, who serves as the Chief Executive Officer (CEO) and is 53 years old.

Wienand has been in this position since June 30, 2024. Philippe Deecke, also 53 years old, serves as the Director of Finance/CFO and has been in this role since November 30, 2021.

Maria Nunez, the Chief Operating Officer, is 56 years old and has been in this position since July 31, 2022. Andreas Bohrer, the General Counsel, has been in his position since December 31, 2014, but his age is not publicly disclosed.

Here is a brief overview of the Executive Committee:

The Board Composition of Lonza Group AG is made up of experienced and diverse individuals.

The oldest member of the board is Jürgen B. Steinemann, who is 67 years old and has been a Director/Board Member since 2014-04-15.

The board members have a range of backgrounds and experience, with some having been members for over a decade.

Barbara Richmond and Angelica Kohlmann are both 65 years old and have been Directors/Board Members since 2014-04-15 and 2018-05-03 respectively.

Explore further: Ohio E Check Years

The most recent additions to the board are Juan Andres, Eric Drapé, and David Meline, who all became Directors/Board Members on 2025-05-08.

Here is a list of the current Board of Directors members:

As we explore the leadership and governance of Lonza Group AG, let's take a closer look at who holds the reins. The company's shareholders are a diverse group, with various institutions and entities owning stakes in the company.

Norges Bank Investment Management holds a significant stake in the company, with 2,166,785 shares, accounting for 3% of the company's equities.

Rathbones Asset Management Ltd. also holds a notable stake, with 190,601 shares, representing 0.2639% of the company's equities.

The company's largest shareholder, however, is Lonza Group AG itself, with 2,159,562 shares, accounting for 2.99% of the company's equities.

Here's a breakdown of the top shareholders:

Nordea Investment Management AB and Capfi Delen Asset Management NV also hold stakes in the company, with 188,859 and 169,589 shares, respectively, accounting for 0.2615% and 0.2348% of the company's equities.

Explore further: What Car Companies Are Offering 0 Financing

Lonza Group is a company that offers premium industry data and analytics, helping you stay ahead of the market.

Their products will be commercialized, allowing you to contend with shifting product portfolios.

You can find Lonza Group's stock on the stock market, specifically listed as LONN Stock.

Lonza Group AG is the company behind this stock.

Lonza Group's stock is categorized under the sector of Stock Market, which includes Equities.

For more insights, see: Unitedhealth Group's Telecommuter Policy

Lonza Group has a strong focus on clinical trials, which is evident in their clinical operations and recruitment strategies.

Their clinical trials are a key part of their business, allowing them to gain valuable insights into new products and treatments.

Determine Lonza Group's go-to-market proposition by examining their clinical trials, which provide a clear understanding of their approach to product development.

To stay on top of Lonza Group's developments, it's essential to keep track of their catalyst impacts. This can be done by proactively evaluating their catalyst effects to improve corporate planning.

The Catalyst Calendar is a valuable tool for staying ahead of the competition. By using it, you can bolster business development with timely opportunities.

Recommended read: Catalyst Capital Group

When planning an event, a video can be a great way to capture the excitement and share it with others.

A video can be recorded using a smartphone or a dedicated camera, and edited using free or low-cost software.

Many events, such as concerts and conferences, are now live-streamed on social media platforms like Facebook and YouTube.

Event organizers can use video to promote their event, share behind-the-scenes content, and create a sense of community among attendees.

Video can also be used to document the event, providing a keepsake for attendees and a record of the event for future reference.

By incorporating video into an event, organizers can increase engagement, build a sense of community, and create lasting memories.

On a similar theme: Using Cash vs Card Psychology

A Catalyst Calendar can be a game-changer for your business, helping you stay ahead of the competition and improve corporate planning.

You can use it to proactively evaluate the impacts of catalysts like Lonza Group Ltd's on your industry, identifying timely opportunities for business development.

With a Catalyst Calendar, you can bolster business development and make informed decisions about investments and partnerships.

By staying on top of catalysts, you can anticipate and respond to market shifts, gaining a competitive edge in your industry.

For more insights, see: Catalyst Pharmaceuticals